|
Information for
Hospital Executives
Overview
Business Case
eLearning Calendar
About Blood Management
What is Blood Management?
Why Blood Management?
10 Facts About Blood
The Strategic Blood Management™ System
Blood Management Perspectives
References
Client List
Client Testimonials
|
INFORMATION FOR HOSPITAL EXECUTIVES
Overview
The transfusion of blood products is a frequent and expensive event. Twenty nine million blood components were transfused in 2004 in the United States, and that number is increasing annually. Blood products alone cost the healthcare system $5 billion each year, and processing and transfusion administration costs add an additional $20 billion. In total, the cost to transfuse patients in the U.S. represents almost 5% of annual hospital expenditures. Of great significance is the fact that a large portion of these blood products are not administered according to evidence-based practices, thereby incurring costs without benefit. A growing body of research has shown that blood transfusions correlate highly with increased rates of infection and poorer clinical outcomes. As a result, unnecessary transfusions are not only wasteful but are harmful and need to be avoided.
What is Blood Management >>
Why Blood Management >>
Ten Facts About Blood Transfusions >>
A Strategic Approach to Blood Management
Strategic Blood Management™ is a suite of products developed by Strategic Healthcare Group LLC that have a proven track record of reducing blood product expenses in major medical centers by up to 37% (client list). The Strategic Blood Management™ suite of products improves the fiscal and clinical dimensions of hospital performance (view business case).
The Strategic Blood Management™ System >>
|
“By using blood appropriately, we have a great opportunity to improve care delivery and improve financial performance. From my perspective as a CEO and as a physician, it is hard to ignore an initiative that improves the bottom line and quality care”
“Our savings through better blood management in policy and procedure implementation—over $400,000 so far (at six months).”
“Where we want to be at the end of the day is that all of the dollars expended for the community blood supply by an individual hospital is an appropriate expenditure of hospital resources and that it’s used in a manner that is most appropriate for the patient so that you have very positive outcomes and you are able to control your costs through utilization.”
|
